Kevin美股成长价投2019-12-31 06:31
$Orgenesis(ORGS)$ $BioLife Solutions(BLFS)$ 近几年美国细胞治疗和再生医学领域发展迅速,投入资本年增长速度超过20%,Orgs为其它公司提供研发服务。算是这波细胞治疗和再生医学淘金热潮里卖铲子的商家。所以近几年公司录的非常稳定而高速的营收增长。股价从高位大幅调整下来,已经开始修复,目...查看全文
牛唐2019-10-11 22:12
$BioLife Solutions(BLFS)$ 全部收购了SAVSU,受益于细胞疗法的火热,2019年收入指引是增长39%,毛利率是七成左右,目前股价回调的厉害,可以关注查看全文
$BioLife Solutions(BLFS)$ 内部交易: 2021-02-01,Exec VP & Chief Scientific Off,Mathew Aby J. ,期权,18484普通股, $1.12
$BioLife Solutions(BLFS)$ 内部交易: 2021-02-02,Exec VP & Chief Scientific Off,Mathew Aby J. ,期权,18484普通股, $1.12
$BioLife Solutions(BLFS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-001915 Size: 13 KB 网页链接
$BioLife Solutions(BLFS)$ 内部交易: 2021-01-25,10% Owner,VILLIGER WALTER ,卖出,50000普通股, $41.58
$BioLife Solutions(BLFS)$ 内部交易: 2021-01-22,10% Owner,VILLIGER WALTER ,卖出,29811普通股, $42.48
$BioLife Solutions(BLFS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-001310 Size: 7 KB 网页链接
$BioLife Solutions(BLFS)$ 内部交易: 2021-01-20,10% Owner,VILLIGER WALTER ,卖出,29182普通股, $41.03
$BioLife Solutions(BLFS)$ 内部交易: 2021-01-19,10% Owner,VILLIGER WALTER ,卖出,40000普通股, $40.30
$BioLife Solutions(BLFS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-001039 Size: 7 KB 网页链接
$BioLife Solutions(BLFS)$ 内部交易: 2021-01-15,10% Owner,VILLIGER WALTER ,卖出,29338普通股, $40.62